Tag: Financial Times

Browse our exclusive articles!

Media Giants Forge AI Partnerships: Impact on Journalism & Personal Data

Discover the impact of media giants partnering with AI firms on journalism & personal data. Stay informed on the latest developments in the industry.

OpenAI Research Scientist Andrej Karpathy Leaves Company to Pursue Personal Projects

OpenAI's Andrej Karpathy leaves for personal projects while CEO Sam Altman pursues AI chip plant discussions with TSMC. Dynamic changes ahead for OpenAI.

8 Unmissable TNW Conference 2023 Highlights from Day 1

Join the TNW Conference 2023 in Amsterdam from June 15-16! Discover the top 8 events on day one, network, and learn from 200+ speakers and 1,500+ startups.

Sam Altman Raises $115 Million for Worldcoin, Backed by Prominent Investors – OpenAI CEO

Sam Altman, co-founder of Worldcoin, recently closed a successful Series C funding round with an investment of $115 million, led by Blockchain Capital. Worldcoin's mission is to provide universal access to the global economy regardless of location or background, and tokens will be issued to users who verify their identity through iris scans. Despite criticism, Sam Altman, OpenAI Chief Executive, continues to invest heavily in startups and technology companies, receiving recognition from multiple sources.

OpenAI CEO Launches Startup to Provide Cryptocurrency to Iris-Scanning Participants

Worldcoin is providing free cryptocurrency tokens for users who agree to have their irises scanned. However, some have voiced concerns about the start-up's use of biometric data and its implementation in different countries. Worldcoin claims it will have millions of users by 2025, but users should be mindful of potential risks to their privacy before signing up.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img